Zobrazeno 11 - 20
of 20
pro vyhledávání: '"Corinna Schlosser"'
Autor:
Birgit Bossenmaier, Corinna Schlosser, Rachida Siham Bel Aiba, Christian Barthels, Benjamin Weiche, Timo Eichner, Michelle Yegres, Shane A. Olwill
Publikováno v:
Cancer Research. 79:3268-3268
Background: Increasing evidence shows that 4-1BB is a key costimulatory immunoreceptor and a highly-promising therapeutic target in cancer. Current antibody-based approaches showed immune cell activation not only in tumor tissues, but also in the per
Autor:
Hsin-Fang Chang, Marta Zagrebelsky, Michael Haberl, Christine Stadelmann, Jens Frahm, Cassandra Flügel-Koch, Holger M. Reichardt, Takashi Watanabe, Nils Schweingruber, Arianna Merlini, Henrike Körner, Dmitri Lodygin, Moritz Hermann, Corinna Schlosser, Sebastian Kügler, Alexander Flügel, Francesca Odoardi, Henrike J. Fischer, Brit Mollenhauer, Dirk Fitzner
Publikováno v:
Nature. 567:E15-E15
In this Article, owing to an error during the production process, the y-axis label of Fig. 2c should read "Number of Tβ-syn cells" rather than "Number of T1β-syn cells" and the left and right panels of Fig. 4 should be labelled 'a' and 'b', respect
Autor:
Louis Matis, Rachida-Siham Bel Aiba, Sven Berger, Marlon Hinner, Shane Olwill, Andrea Allersdorfer, Corinna Schlosser, Christine Rothe, Manuela Carola Dürr, Thomas Jaquin
Publikováno v:
Cancer Research. 77:3673-3673
Background. 4-1BB (CD137) is a key costimulatory immunoreceptor and a highly promising therapeutic target in cancer. To overcome toxicity and efficacy limitations of current 4-1BB targeting antibodies, we have developed PRS-343, a 4-1BB/HER2 bispecif
Autor:
Thomas Jaquin, Gabriele Matschiner, Julia Schüler, R.S. Bel Aiba, Corinna Schlosser, Shane A. Olwill, Andrea Allersdorfer, Sven Berger, Ulrich Moebius, Christine Rothe, Alexander Wiedenmann, Marlon Hinner
Publikováno v:
European Journal of Cancer. 69:S99
Autor:
Julia Schüler, Ulrich Moebius, Alexander Wiedenmann, Shane Olwill, Marlon Hinner, Corinna Schlosser, Sven Berger, Rachida-Siham Bel Aiba, Christine Rothe, Thomas Jaquin, Gabriele Matschiner, Andrea Allersdorfer
Publikováno v:
Cancer Immunology Research. 4:B016-B016
Background: CD137 (4-1BB) is a key costimulatory immunoreceptor and a member of the TNF-receptor (TNFR) superfamily. While multiple lines of evidence show that CD137 is a highly promising therapeutic target in cancer, current mAb-based approaches are
Autor:
Gabriele Matschiner, Corinna Schlosser, Sven Berger, Marlon Hinner, Ulrich Moebius, Christine Rothe, Alexander Wiedenmann, Andrea Allersdorfer, Rachida-Siham Bel Aiba, Shane Olwill
Publikováno v:
Cancer Research. 76:556-556
Background. CD137 (4-1BB) is a key costimulatory immunoreceptor and a member of the TNF-receptor (TNFR) superfamily. While multiple lines of evidence show that CD137 is a highly promising therapeutic target in cancer, current mAb-based approaches are
Autor:
Rachida-Siham Bel Aiba, Gabriele Matschiner, Marlon Hinner, Shane Olwill, Alexander Wiedenmann, Christine Rothe, Andrea Allersdorfer, Corinna Schlosser, Ulrich Moebius
Publikováno v:
Cancer Immunology Research. 4:B023-B023
Background: CD137 is a potent costimulatory immunoreceptor and a member of the TNF-receptor (TNFR) superfamily. The receptor, also known as 4-1BB, is mainly expressed on activated CD4+ and CD8+ T cells, activated B cells, and natural killer (NK) cell
Autor:
Marlon Hinner, Gabriele Matschiner, Shane Olwill, Holbrook E Kohrt, Ulrich Moebius, Christine Rothe, Alexander Wiedenmann, Corinna Schlosser, Andrea Allersdorfer, Rachida-Siham Bel Aiba
Publikováno v:
Molecular Cancer Therapeutics. 14:C205-C205
CD137 is a potent costimulatory immunoreceptor and a member of the TNF-receptor (TNFR) superfamily. The receptor, also known as 4-1BB, is mainly expressed on activated CD4+ and CD8+ T cells, activated B cells, and natural killer (NK) cells. While mul
Autor:
Andrea Allersdorfer, Alexander Wiedenmann, Holbrook E Kohrt, Christine Rothe, Corinna Schlosser, Gabriele Matschiner, Shane Olwill, Marlon Hinner, Ulrich Moebius, Rachida-Siham Bel Aiba
Publikováno v:
Journal for Immunotherapy of Cancer
Meeting abstracts CD137 is a potent costimulatory immunoreceptor and a member of the TNF-receptor (TNFR) superfamily. The receptor, also known as 4-1BB, is mainly expressed on activated CD4+ and CD8+ T cells, activated B cells, and natural killer (NK
Autor:
Corinna Schlosser, Angelika Schmitt, Edna Grünblatt, Jasmin Bartl, Manfred Gerlach, Susanne Walitza, Pille Link, Peter Riederer
Publikováno v:
Attention deficit and hyperactivity disorders. 2(4)
The psychostimulant methylphenidate (MPH) is the first choice of treatment in attention-deficit hyperactivity disorder and is based mainly on inhibition of dopamine transporter (DAT). Nonetheless, the complete cellular effects of MPH are still unknow
- [1]
- « Předchozí
- 1
- 2